NCT00771693View on ClinicalTrials.gov

Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Type 2 Diabetes MellitusPostprandial Hyperglycemia
Interventions
DRUG

Insulin aspart (Novorapid®)

a cross-over study with subcutaneous injection of insulin aspart 0.1U/kg, 0.2u/kg or placebo, before the meal, on 3 different occasions.

Trial Locations (1)

SE 171 76

Department of Medicine, Clinical pharmacology Unit, Karolinska University Hospital, Solna., Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT00771693 - Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM) | Biotech Hunter | Biotech Hunter